
TG Therapeutics, Inc. (TGTX) stock: analyst price target and their real reliability
📈 TG Therapeutics, Inc. (TGTX) stock price
🎯 TGTX price target & analyst consensus — price $55.72
⭐ The most reliable of them, either direction: HC Wainwright & Co. — 61% of its targets hit on this sector (321 calls tested). It aims for $77 (+38 %), call made on July 14, 2026, maturing on July 14, 2027 (45 d ago).
All 61 calls, one by one, with our verdict on each firm.
→ See all 61 targets, analyst by analystTheir real reliability on TGTX, firm by firm: who was right, who was wrong.
→ See their reliability on TGTX🔎 Detailed analyses
✅ Historical analyst reliability on TGTX
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Jefferies ↗ | 100% | +88.6% | 2 |
| JP Morgan ↗ | 80% | +88.6% | 5 |
| B. Riley Securities ↗ | 77% | +106.5% | 13 |
| Ladenburg Thalmann ↗ | 75% | +133.6% | 4 |
| Cantor Fitzgerald ↗ | 67% | +61.7% | 6 |
| Evercore ISI Group ↗ | 67% | +1.1% | 3 |
| Goldman Sachs ↗ | 67% | -17.2% | 6 |
| HC Wainwright & Co. ↗ | 64% | +31.6% | 33 |
| B of A Securities ↗ | 0% | -247.2% | 2 |
📊 What $1,000 invested in TG Therapeutics, Inc. would be worth › open the full page
If I'd invested $1,000 in TG Therapeutics, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,824 | +82% |
| 3 years ago | $4,640 | +364% |
| 5 years ago | $1,055 | +6% |
Return by year (TG Therapeutics, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +84% | $1,841 (+84%) |
| 2025 | -1% | $1,824 (+82%) |
| 2024 | +76% | $3,214 (+221%) |
📰 Recent news on TG Therapeutics, Inc.
📋 All analyst calls on TGTX
matures : Aug 7, 27
matures : Jul 27, 27
matures : Jul 13, 27
matures : Jul 7, 27
matures : Jul 6, 27
matures : May 27, 27
matures : May 6, 27
matures : Feb 2, 27
See the other 53 calls, newest to oldest
matures : Jan 15, 27
matures : Nov 3, 26
matures : Sep 17, 26
matures : Nov 5, 25
matures : Aug 7, 25
matures : Feb 28, 25
matures : Aug 2, 24
matures : Aug 1, 24
Frequently asked questions
Should I buy TG Therapeutics, Inc. stock?
This isn't buy advice. For TG Therapeutics, Inc., the analyst consensus is "Buy", with an average price target of $74.50 (+34% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on TG Therapeutics, Inc.). We show the numbers — you decide.
Is it too late to buy TG Therapeutics, Inc.? How high can it go?
The most bullish analyst target on TG Therapeutics, Inc. is $86.00 (+54% above today's price); the average is $74.50. That's the upside they see. Check how reliable those analysts have actually been on TG Therapeutics, Inc. on our site before trusting it.
Is TG Therapeutics, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 9 analysts have a real record on TG Therapeutics, Inc., the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
What has TG Therapeutics, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: TGTX performance & returns.
What is the best month to buy TGTX?
The 12 months ranked by the stock's past returns: best & worst month to buy TGTX.